We evaluated the sensitivity of the commercially available NS1-based IgM, IgAM, and IgG ELISAs in a panel of acute (illness day 1–5) and follow-up (illness day ≥ 6) samples from 77 patients with RT-PCR confirmed ZIKV infection (Table 2). The gene discussed is CD40LG; the disease is Zika virus infectious disease.